Profound Global Operations
Profound Global Operations
Fosun’s globalization strategy means more than just “two-way engagement” between the global and Chinese markets.
It extends to the endogenous development of its ecosystem enterprises both domestically and internationally, encouraging them to actively expand their businesses beyond their domestic markets.
It extends to the endogenous development of its ecosystem enterprises both domestically and internationally, encouraging them to actively expand their businesses beyond their domestic markets.
-
49.16 billion
Overseas revenue in 1H2026
-
56.5 %
Proportion of overseas revenue in 1H2026
Growth driven by both domestic and overseas insurance companies
- FidelidadeMaintained its leading position in Portugal, with an overall market share of 30.1%. Its international business continued to grow rapidly, accounting for 26.7% of its consolidated total business, with Latin America accounting for over 60%. In 1H2026, net profit attributable to owners of the parent amounted to EUR165 million, up 23.8% yoy
- Peak ReinsuranceContinued to deepen its presence in India while further strengthening its footprint in Europe and North America. In 1H2026, reinsurance revenue and gross written premiums increased by 25.0% and 11.8% yoy respectively, while net profit after tax reached USD89.70 million
- Pramerica Fosun Life InsuranceAchieved growth in both scale and value. In 1H2026, gross written premiums increased by 52.2% yoy, while net profit reached RMB780 million, up 270% yoy
- Fosun United Health InsuranceHas developed a distinctive service system built around four pillars. In 1H2026, its business revenue increased by 36.2% yoy, while net profit reached RMB572 million
Overseas launch of innovative pharmaceutical products
- HenliusHenlius had 10 products approved in over 60 countries and regions
- AR1001Fosun Pharma and AriBio entered into an exclusive global option agreement for AR1001, a drug candidate for the treatment of Alzheimer's disease
- HANQUYOUHANQUYOU has been approved for marketing in over 50 countries and regions and has been included in reimbursement systems in China, the U.K., France, Germany and other countries. (delete the sales figure)
- HANSIZHUANGHANSIZHUANG was approved for 3 new indications in the European Union (EU) in 1H2026 and is now available in more than 50 countries and regions worldwide
- HLX11HLX11 (POHERDY) became the world's first pertuzumab biosimilar to be approved in the EU
- Fosun HealthFosun Health has built an open, stable and professional international medical collaboration network, actively expanding into markets including Indonesia, Bangladesh, Mongolia, Hong Kong SAR and Macau SAR
Deepening global operations through global expansion
- FidelidadeFidelidade maintained its leading position in Portugal, while its international business continued to grow rapidly, accounting for 26.7% of its consolidated total business
- WanshengWansheng's phosphate ester flame retardant project at its Thailand facility successfully commenced operations
- YuyuanIn 1H2026, Yuyuan's revenue from Hong Kong SAR and Macau SAR increased by 285.83% yoy, while its revenue from Japan grew by 6.09% yoy. Its subsidiary, Laomiao, now has 15 stores across Hong Kong SAR, Macau SAR, overseas markets and duty-free channels, while Nanxiang opened 3 new stores overseas
- Club MedClub Med operates nearly 70 resorts worldwide and continues to expand its global destination network. The resort in Hangzhou Longwu officially opened in April 2026, while the Beach & Safari resort in South Africa had its soft opening in July 2026
- Hainan MiningHainan Mining has built a global resource portfolio spanning multiple strategic minerals. Its integrated value chain of Bougouni Lithium Mine in Mali + Hainan Xingzhihai Lithium Salt Processing has been operating steadily
